21596 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins; Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies radioimmunotoxins, i.e. conjugates being structurally as defined in , and including a radioactive nucleus for use in radiotherapeutic applications
RADIOPHARMACEUTICAL MOFS FOR MEDICAL IMAGING
#2CLAUDIN 18.2-TARGETED COMPOUNDS AND USES THEREOF
#3ANTIBODIES TARGETING CD47 AND USES THEREOF
#4CD138/SYNDECAN1 ANTIBODIES AND METHODS OF USE THEREOF
#5MOFS WITH BETA-EMITTERS FOR RADIOTHERAPY
#6AGENTS FOR CLEAVING LABELS FROM BIOMOLECULES IN VIVO
#7THERAPEUTIC AGENTS AND USES THEREOF
#85T4 BINDING POLYPEPTIDES AND USES THEREOF
#9HUMANIZED ANTI-CD45 ANTIBODIES AND USES THEREOF
#10RADIOPHARMCEUTICAL COMPLEXES TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN AND ITS COMBINATIONS
#11MODULAR SELF ASSEMBLY DISASSEMBLY (SADA) TECHNOLOGIES
#12METHODS FOR TREATING CANCER USING COMBINATIONS OF EPIGENETIC THERAPIES AND RADIOCONJUGATE TARGETING AGENTS
#13COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME
#14HER3 RADIOIMMUNOTHERAPY FOR THE TREATMENT OF SOLID CANCERS
#15RADIOLABELING OF POLYPEPTIDES
#16RADIOACTIVE COMPLEX OF ANTI-VEGF ANTIBODY, AND RADIOPHARMACEUTICAL
#17IMPROVED ANTIBODY-PAYLOAD CONJUGATES (APCS) PREPARED BY SITE-SPECIFIC CONJUGATION UTILIZING GENETIC CODE EXPANSION
#18IIMMUNOCONJUGATES COMPRISING KALLIKREIN RELATED PEPTIDASE 2 ANTIGEN BINDING DOMAINS AND THEIR USES
#19ANTIMONY CHELATES FOR TARGETED AUGER THERAPY AND IMAGING DIAGNOSTICS
#20MACROCYCLIC COMPOUNDS AND METHODS OF MAKING THE SAME
#21METHODS FOR TREATING CD33-POSITIVE HEMATOLOGICAL MALIGNANCIES
#22DLL3 BINDING MOLECULES AND USES THEREOF
#23METHODS OF TREATING CANCER
#24ANTI-MESOTHELIN NANOBODIES AND USE THEREOF
#25USE OF ANTI-B7H3 ANTIBODIES FOR TREATING CANCER IN THE CENTRAL NERVOUS SYSTEM
#26EGFRVIII-TARGETED COMPOUNDS AND USES THEREOF
#27RADIOLABELING OF POLYPEPTIDES
#28RADIOIMMUNOCONJUGATES TARGETING GRP78 FOR USE IN THE TREATMENT OF CANCER
#29Structural Optimization Method to Improve the Theranostic Performance of Peptide Receptor-Targeted Radionuclide Therapy for Cancers
#30ANTI-NECTIN-4 ANTIBODY, DRUG CONJUGATE, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#31REAGENTS FOR SITE-SPECIFIC LABELING OF PROTEINS WITH RADIOHALOGENS, AND METHODS OF MAKING AND USING THE SAME
#32Netrin-1 detection, companion test and therapy based on radiations
#33RADIONUCLIDE MICROSPHERES AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#34ISOLATED POLYPEPTIDE AND USE THEREOF
#35RADIOACTIVE COMPLEX OF DEGLYCOSYLATED ANTIBODY AND RADIOACTIVE PHARMACEUTICAL PRODUCT
#36ANTI-CLDN18.2 ANTIBODY CONJUGATES
#37ANTI-oxMIF RADIOIMMUNOCONJUGATE
#38RADIOLABELED ANTI-LAG3 ANTIBODIES FOR IMMUNO-PET IMAGING
#39METHODS AND MATERIALS FOR COMBINING BIOLOGICS WITH MULTIPLE CHELATORS
#40SYNTHESIS OF RESTRAINED COMPLEXING AGENTS
#41THERAPEUTIC CONJUGATES
#42MATERIALS AND METHODS FOR BINDING SIGLEC-3/CD33
#43RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY
#44ANTI-CD38 SINGLE DOMAIN ANTIBODIES IN DISEASE MONITORING AND TREATMENT
#45PRECISION RADIOPHARMACEUTICAL THERAPY OF LYMPHOMA AND OTHER DISEASES
#46RIGIDIFIED MACROCYCLES, COMPLEXES WITH RADIONUCLIDES, AND USE IN TARGETED RADIOTHERAPY OF CANCER
#47MACROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF
#48Improved immunoglobulin II
#49RADIOLIGAND BINDING TO ANTI-DLL3 ANTIBODIES FOR PRETARGETED PET IMAGING AND THERAPEUTIC USES THEREOF
#50PEPTIDE-FC FUSIONS FOR TREATING AMYLOID DISORDERS
#51CD8 BINDING POLYPEPTIDE AND USE THEREOF
#52FOLR1 BINDING AGENTS, CONJUGATES THEREOF AND METHODS OF USING THE SAME
#53RADIOACTIVE COMPLEX OF ANTI-CD20 ANTIBODY, AND RADIOPHARMACEUTICAL
#54RADIOACTIVE COMPLEX OF ANTI-EGFR ANTIBODY, AND RADIOPHARMACEUTICAL
#55IMMUNOCONJUGATES FOR TARGETED RADIOISOTOPE THERAPY
#56METHOD FOR STORING INTERMEDIATE FOR RADIOPHARMACEUTICAL COMPOSITION, METHOD FOR PREPARATION OR STORAGE OF RADIOPHARMACEUTICAL COMPOSITION, INTERMEDIATE COMPOSITION FOR RADIOPHARMACEUTICAL COMPOSITION, AND PHARMACEUTICAL FORMULATION
#57HUMANISED ANTIBODIES LABELLED WITH RADIONUCLIDES THAT EMIT BETA-RAYS
#58COMBINATION THERAPY
#59COMPOUND AND LABELED BIOLOGICAL SUBSTANCE USING THE SAME
#60ANTI-CD45-BASED CONDITIONING METHODS AND USES THEREOF IN CONJUNCTION WITH GENE-EDITED CELL-BASED THERAPIES
#61MULTIMERIC CHELATOR COMPOUNDS FOR USE IN TARGETED RADIOTHERAPY
#62METHODS OF TREATING CANCER
#63ANTIBODIES BINDING TO SARS-COV-2 VIRUS AND USES THEREOF
#64LRRC15 ANTIBODIES AND CONJUGATES THEREOF
#65METHODS FOR TREATING HEMATOLOGIC CANCERS
#66AUTONOMOUS KNOB DOMAIN PEPTIDES
#67METHOD FOR PRODUCING RADIOACTIVE ZIRCONIUM COMPLEX
#68CALRETICULIN NANOBODIES
#69METHOD FOR PRODUCING RADIOACTIVE ZIRCONIUM COMPLEX
#70RADIOACTIVE COMPLEXES OF ANTI-HER2 ANTIBODY, AND RADIOPHARMACEUTICAL
#71TROPHOBLAST GLYCOPROTEIN RADIOIMMUNOTHERAPY FOR THE TREATMENT OF SOLID CANCERS
#72MACROCYCLIC COMPLEXES OF ALPHA-EMITTING RADIONUCLIDES AND THEIR USE IN TARGETED RADIOTHERAPY OF CANCER
#73TRANSGLUTAMINASE CONJUGATION METHOD WITH AMINO ACID-BASED LINKERS
#74Materials And Methods For Binding Siglec-3/CD33
#75Materials And Methods For Binding Siglec-3/CD33
#76One-Step Labeling of Antibodies to High Specific Activity with Actinium-225
#77THERAPEUTIC AND DIAGNOSTIC METHODS RELATING TO CANCER STEM CELLS
#78B7H3 Antibodies with Chelators
#79COMBINATION THERAPY FOR TREATING CANCER
#80SYSTEMS, COMPOSITIONS, AND METHODS FOR LOCAL IMAGING AND TREATMENT OF PAIN
#81COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME
#82CYSTEINE LINKED NANOBODY DIMERS
#83FGFR3-TARGETED RADIOIMMUNOCONJUGATES AND USES THEREOF
#84MODULAR SELF ASSEMBLY DISASSEMBLY (SADA) TECHNOLOGIES
#85ANTI-PSMA RADIOCONJUGATES AND USES THEREOF
#86PROCESS FOR SITE-SPECIFIC MODIFICATION OF AN ANTIBODY
#87STRUCTURAL OPTIMIZATION METHOD TO IMPROVE THE THERANOSTIC PERFORMANCE OF PEPTIDE RECEPTOR-TARGETED RADIONUCLIDE THERAPY FOR CANCERS
#88SUSTAINED IMMUNOTHERAPY
#89TARGETED RADIOPHARMACEUTICALS FOR THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER
#90IGF-1R MONOCLONAL ANTIBODIES AND USES THEREOF
#91REACTIVE CONJUGATES
#92COMPOSITIONS AND METHODS FOR THE TREATMENT OF PROSTATE CANCER
#93RADIOIMMUNOCONJUGATE FOR USE IN TREATING BONE MARROW ASSOCIATED DISEASES
#94Trivalent Radioisotope Bio-Targeted Radiopharmaceutical, Methods Of Preparation And Use
#95AGENTS FOR CLEAVING LABELS FROM BIOMOLECULES IN VIVO
#96RADIOLABELLED ANTIBODY FRAGMENTS FOR USE IN TREATING CANCER
#97PARA-AMINOHIPPURIC ACID (PAH) AS A RENAL PROTECTIVE SUBSTANCE
#98Low dose antibody-based methods for treating hematologic malignancies
#99ANTI-CD33 ANTIBODIES FOR TREATING CANCER
#100ANTIBODY POLYPEPTIDES AND USES THEREOF
#101METHODS AND COMPOSITIONS FOR DETERMINING THE BIODISTRIBUTION OF ACTIVATABLE ANTI-CD166 ANTIBODY CONJUGATES
#102CHELATORS AND METHODS OF MAKING AND USING SAME
#103TREATMENT OF NON-HODGKIN LYMPHOMA USING LILOTOMAB AND 177LU-LILOTOMAB SATETRAXETAN
#104COMPOSITIONS AND METHODS FOR RADIOTHERAPY USING CHELATED RADIOTHERAPEUTIC AGENTS AND NON-TARGET TISSUE BLOCKADE
#105MACROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF
#106RADIO-PHARMACEUTICAL COMPLEXES
#107Antibodies Conjugated With Actinium-225 and Actinium-227, and Related Compositions and Methods
#108THERAPEUTIC AGENTS AND USES THEREOF
#109STABILIZED RADIOLABELED ANTI-CD45 IMMUNOGLOBULIN COMPOSITIONS
#110C-terminal lysine conjugated immunoglobulins
#111Humanised Anti Kallikrein-2 Antibody
#112COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME
#113CD8 IMAGING CONSTRUCTS AND METHODS OF USE THEREOF
#114Therapeutic and diagnostic methods relating to cancer stem cells
#115COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME
#116ANTI-CD45-BASED LYMPHODEPLETION METHODS AND USES THEREOF IN CONJCTION WITH ACT-BASED CANCER THERAPIES
#117Androgen Receptor Modulator And Uses Thereof
#118Modified antibody and radioactive metal-labelled antibody
#119RADIOIMMUNOCONJUGATES IN COMBINATION WITH OTHER DRUGS AS TREATMENT AGAINST NHL
#120Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer
#121SYSTEMS, COMPOSITIONS, AND METHODS FOR LOCAL IMAGING AND TREATMENT OF PAIN
#122Anti-mica antigen binding fragments, fusion molecules, cells which express and methods of using
#123Radiolabeling of polypeptides
#124Cu(I)-catalyzed azide-alkyne cycloadditions (CuAAC) ligands and methods for carrying out Cu(I)-catalyzed azide-alkyne cycloaddition reactions
#125THERAPEUTIC AND DIAGNOSTIC METHODS RELATING TO CANCER STEM CELLS
#12618F labeling of proteins using sortases
#127Methods for treating hematologic cancers
#128Antibodies to centrin-1, methods of making, and uses thereof
#129METHODS FOR CANCER TREATMENT USING A RADIOLABELED ANTI-CD45 IMMUNOGLOBULIN AND ADOPTIVE CELL THERAPIES
#130Anti-CD45-based conditioning methods and uses thereof in conjunction with gene-edited cell-based therapies
#131THE OPTIMAL 225ACTINIUM--213BISMUTH GENERATOR FOR ALPHA-PARTICLE RADIOIMMUNOTHERAPY
#132USE OF ANTI-B7H3 ANTIBODIES FOR TREATING CANCER IN THE CENTRAL NERVOUS SYSTEM
#133ENHANCED TARGETED DELIVERY OF THERAPEUTIC AGENTS
#134Modular self assembly disassembly (SADA) technologies
#135THERAPEUTIC AGENTS AND USES THEREOF
#136Light chain variable regions
#137Anti-human CEACAM5 antibody Fab fragment
#138Modified variable domain molecules and methods for producing them
#139Tumor targeted radionuclide therapy and molecular imaging of HER2+ cancers and other neoplasms
#140Internalizing human monoclonal antibodies targeting prostate and other cancer cells
#141Methods to Impair Hematologic Cancer Progenitor Cells and Compounds Related Thereto
#142C-terminal lysine conjugated immunoglobulins
#143RADIOIMMUNOCONJUGATE FOR USE IN TREATING BONE MARROW ASSOCIATED DISEASES
#144HER3 inhibitor for modulating radiosensitivity
#145Stabilized radio-labeled anti-CD45 immunoglobulin compositions
#146Amnion coated embolic agents for treating tumors
#147Low dose antibody-based methods for treating hematologic malignancies
#148DLL3 MODULATORS AND METHODS OF USE
#149SYSTEMS, COMPOSITIONS, AND METHODS FOR LOCAL IMAGING AND TREATMENT OF PAIN
#150Preparation of Pb labeled monoclonal antibodies
#151TREATMENT OF NON-HODGKIN LYMPHOMA USING LILOTOMAB AND 177LU-LILOTOMAB SATETRAXETAN
#152Stabilized radiolabeled anti-CD45 immunoglobulin compositions
#153Humanised anti kallikrein-2 antibody
#154Radio-pharmaceutical complexes
#155IGF-1R monoclonal antibodies and uses thereof
#156Methods and materials for treating tumors
#157CD20 BINDING AGENTS AND USES THEREOF
#158DLL3 MODULATORS AND METHODS OF USE
#159Therapeutic antibodies and uses thereof
#160Method for upregulating antigen expression
#161Antibody polypeptides and uses thereof
#162Novel Antibody And Use In Diagnosis And Therapy Of Arthropathies
#163Radiolabelled antibody fragments for use in treating cancer
#164Anti-VEGFR antibody and uses thereof
#165Anti-ROR1 antibodies
#166Systems and methods for determining optimum patient-specific antibody dose for tumor targeting
#167Anti-MICA antigen binding fragments, fusion molecules, cells which express and methods of using
#168ANTI-PD-L1 IMMUNOTOXIN FOR USE IN THERAPY
#169Methods of delivering DLL3 antibody drug conjugates
#170Methods of making DLL3 antibody drug conjugates
#171Anti-DLL3 antibody drug conjugates and methods of use
#172Anti-DLL3 antibody drug conjugates
#173Functionalized linear ligands and complexes thereof
#174Cysteine linked nanobody dimers
#175Stabilized radiolabeled anti-CD45 immunoglobulin compositions
#176RADIOIMMUNE COMPLEX, THERANOSTIC AGENT AND KIT
#177Kits containing DLL3 antibody drug conjugates
#178Cu(I)-catalyzed azide-alkyne cycloadditions (CuAAC) ligands and methods for carrying out Cu(I)-catalyzed azide-alkyne cycloaddition reactions
#179Anti-DLL3 antibody drug conjugates
#180Anti-DLL3 antibody drug conjugates for treating cancer
#181Methods of making DLL3 antibody drug conjugates
#182Methods of delivering DLL3 antibody drug conjugates
#183Anti-DLL3 antibody drug conjugates
#184Internalizing human monoclonal antibodies targeting prostate and other cancer cells
#185Anti-CD40 antibodies and methods of treating cancer having CD40+ tumor cells
#186MODIFIED VARIABLE DOMAIN MOLECULES AND METHODS FOR PRODUCING THEM
#187ANTI-VEGFR ANTIBODY AND USES THEREOF
#188Camptothecin Conjugates of Anti-CD22 Antibodies for Treatment of B Cell Diseases
#189One-step labeling of antibodies to high specific activity with actinium-225
#190Antagonists for abdominal vasopressin V2 receptor and uses thereof
#191ALLOGRAFT REJECTION TEST
#192METHODS OF TREATMENT OF CANCER
#193Anti-DLL3 antibody drug conjugates for treating cancer
#194Humanised anti kallikrein-2 antibody
#195Radio-imaging and radio-therapy of cancer using antibodies to HAAH
#196Therapeutic Agents and Uses Thereof
#197Y-90-LABELED ANTI-CD22 ANTIBODY (EPRATUZUMAB TETRAXETAN) IN REFRACTORY/RELAPSED ADULT CD22+ B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
#198F labeling of proteins using sortases
#199Anti-DLL3 antibody drug conjugates
#200Novel Antibody And Use In Diagnosis And Therapy Of Arthropathies
#201Methods for treating hematologic cancers
#202ANDROGEN RECEPTOR MODULATOR AND USES THEREOF
#203COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME
#204RADIOSENSITIVITY OF FLUOROPHORES AND USE OF RADIOPROTECTIVE AGENTS FOR DUAL-MODALITY IMAGING
#205METHODS OF IDENTIFYING SURROGATE IMAGING AGENTS FOR ALPHA EMITTER RADIOPHARMACEUTICALS AND THEIR USE IN TREATMENT OF DISEASE
#206Labeled ligands of anti-Mullerian hormone for diagnosis of endometriosis
#207IMMUNO-PET IMAGING OF ANTIBODIES AND IMMUNOCONJUGATES AND USES THEREFOR
#208Systems, compositions, and methods for local imaging and treatment of pain
#209Pathogen Binding Agents Conjugated to Radioisotopes and Uses in Imaging and Therapeutic Applications
#210METHOD FOR UPREGULATING ANTIGEN EXPRESSION
#211HELICAL POLYCARBODIIMIDE POLYMERS AND ASSOCIATED IMAGING, DIAGNOSTIC, AND THERAPEUTIC METHODS
#212Radio-labelled antibody fragments for use in the prevention and/or treatment of cancer
#213Assessment of labeled probes in a subject
#214Method of imaging a cardiovascular disease with an anti-macrophage mannose receptor immunoglobulin single variable domain
#215INTRAOPERATIVE DETECTION OF TUMOR RESIDUES USING BETA-RADIATION AND CORRESPONDING PROBES
#216Class I anti-CEA antibodies and uses thereof
#217Anti-Mucin Antibodies for Early Detection and Treatment of Pancreatic Cancer
#218Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
#219Radioisotope trithiol complexes
#220High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection
#221THERAPEUTIC AND DIAGNOSTIC TARGET
#222Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy
#223Methods to impair hematologic cancer progenitor cells and compounds related thereto
#224Class I anti-CEA antibodies and uses thereof
#225Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages
#226IMMUNO-PET IMAGING OF ANTIBODIES AND IMMUNOCONJUGATES AND USES THEREFOR
#227HER3 inhibitor for modulating radiosensitivity
#228Anti-mucin antibodies for early detection and treatment of pancreatic cancer
#229Class I anti-CEA antibodies and uses thereof
#230Therapeutic agents and uses thereof
#231PSMA antibodies and uses thereof
#232METHOD OF RADIOTHERAPY
#233Androgen receptor modulator and uses thereof
#234Class I anti-CEA antibodies and uses thereof
#235Thiol-ene click chemistry for drug conjugates
#236Alpha emitting constructs and uses thereof
#237Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy
#238Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells
#239Radioactive metal-labeled anti-cadherin antibody
#240Class I anti-CEA antibodies and uses thereof
#241Radioimmunoconjugates and uses thereof
#242Anti-mucin antibodies for early detection and treatment of pancreatic cancer
#243METHOD OF USING AN ANTI-CD137 ANTIBODY AS AN AGENT FOR RADIOIMMUNOTHERAPY OR RADIOIMMUNODETECTION
#244Antibody therapy
#245Camptothecin conjugates of anti-CD22 antibodies for treatment of B cell diseases
#246Antibody therapy
#247PSMA antibodies and uses thereof
#248Antibody and use in diagnosis and therapy of arthropathies
#249METHOD OF USING AN ANTI-CD137 ANTIBODY AS AN AGENT FOR RADIOIMMUNOTHERAPY OR RADIOIMMUNODETECTION
#250Class I anti-CEA antibodies and uses thereof
#251High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection
#252Treatment of Proliferative Disorders Using Antibodies to PSMA
#253Alpha-emitting constructs and uses thereof
#254Antibody therapy
#255Radiotherapeutic High Specific Activity Tin-117m and Methods of Use
#256Production of thorium 228 starting from a natural thorium salt
#257Methods to impair hematologic cancer progenitor cells and compounds related thereto
#258Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases
#259Cytotoxicity mediation of cells evidencing surface expression of MCSP
#260Antibody therapy
#261Cytotoxicity mediation of cells evidencing surface expression of CD63
#262Systems, compositions, and methods for local imaging and treatment of pain
#263Recombinant Peptides Derived from the Mc3 Anti-BA46 Antibody, Methods of Use Thereof, and Methods of Humanizing Antibody Peptides
#264Molecular imaging of matrix metalloproteinase expression using labeled chlorotoxin
#265Compositions of PSMA antibodies
#266Cytotoxicity mediation of cells evidencing surface expression of MCSP
#267Cancerous disease modifying antibodies
#268Humanized Antibody
#269Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection
#270ANTIBODY THERAPY
#271Radiotherapeutic high specific activity tin-117m and methods of use
#272Enhancing the effect of radioimmunotherapy in the treatment of tumors
#273Thorium-227 for use in radiotherapy of soft tissue disease
#274Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection
#275Method of treating tumors
#276Targeted combination immunotherapy of cancer and infectious diseases
#277Humanized antibody
#278PSMA formulations and uses thereof
#279Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides
#280Cancer treatment
#281Cytotoxicity mediation of cells evidencing surface expression of MCSP
#282Cancerous disease modifying antibodies
#283Lewis Y radioimmunotherapy for the treatment of cancer